Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Long-term therapy over 2 years with ambroxol (Mucosolvan) retard capsules in patients with chronic bronchitis. Results of a double-blind study of 180 patients].

× No keyword cloud information.

7 in total

Review 1. [Good sense and nonsense of antitussive agents].

Authors: A Gillissen; S Tasci; S Ewig; H Schäfer; S Zielen
Journal: Internist (Berl) Date: 2001-01 Impact factor: 0.743

Review 2. Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review.

Authors: P J Poole; P N Black
Journal: BMJ Date: 2001-05-26

Review 3. Ambroxol: a CNS drug?

Authors: Thomas Weiser
Journal: CNS Neurosci Ther Date: 2008 Impact factor: 5.243

4. Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery.

Authors: Patrícia Severino; Tatiana Andreani; Ana Sofia Macedo; Joana F Fangueiro; Maria Helena A Santana; Amélia M Silva; Eliana B Souto
Journal: J Drug Deliv Date: 2011-11-24

5. Mucolytic Effectiveness of Tyloxapol in Chronic Obstructive Pulmonary Disease - A Double-Blind, Randomized Controlled Trial.

Authors: Martin Koppitz; Charlotte Eschenburg; Emilia Salzmann; Martin Rosewich; Ralf Schubert; Stefan Zielen
Journal: PLoS One Date: 2016-06-16 Impact factor: 3.240

6. Characterization of differential patient profiles and therapeutic responses of pharmacy customers for four ambroxol formulations.

Authors: Peter Kardos; Kai-Michael Beeh; Ulrike Sent; Tobias Mueck; Heidemarie Gräter; Martin C Michel
Journal: BMC Pharmacol Toxicol Date: 2018-07-04 Impact factor: 2.483

7. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.

Authors: Phillippa Poole; Kavin Sathananthan; Rebecca Fortescue
Journal: Cochrane Database Syst Rev Date: 2019-05-20

7 in total